NLJabbari, You're welcome!
Kevin, I
think this is the link to the NIH eltrombopag study that the article mentions, so it looks like DEC 2015. This trial is active but not recruiting new patients:
http://www.clinicaltrials.gov/ct2/sh...ombopag&rank=5.
NIH has three other trials with eltrombopag going on that are still recruiting:
- One for newly diagnosed SAA patients that are getting ATG & Cyclosporine for the first time; they add eltrombopag for the treatment. Looks like this one ends in May 2015:
http://www.clinicaltrials.gov/ct2/sh...ombopag&rank=3
- One for recently treated SAA patients that didn't respond within 6 months to immunosuppression with antithymocyte globulin, alemtuzumab or cyclophosphamide, where NIH treats them with
just eltrombopag and not additional immunosuppression, ends March 2017:
http://www.clinicaltrials.gov/ct2/sh...ombopag&rank=4
- One for people with Moderate Aplastic Anemia where NIH treats them with just eltrombopag, and not immunosuppression, ends DEC 2014. It looks like you could have had a prior treatment with ATG/cyclosporine but not within the 6 months prior to the clinical trial:
http://www.clinicaltrials.gov/ct2/sh...ombopag&rank=1